Astra makes machine learning bet with Benevolent AI deal
Astrazeneca has made another push into artificial intelligence, but admits that it will be some time before it knows whether the technology has helped its drug discovery…
For drug treatment decisions machine learning must be more than a black box
The industry has its work cut out to rebuild trust in the tech following doubts about one pioneer, IBM Watson.
Big pharma piles into machine learning, but what will it get out of it?
Big pharma is using machine learning to improve the drug development process – but can the tech live up to the hype?
Artificial intelligence is the real thing for pharma and medtech
Advances in computing power and machine learning could drastically change the way drugs are developed and paid for.
